Analysis of MSH3 in Endometrial Cancers With Defective DNA Mismatch Repair

Objective: To clarify the origin of defective mismatch repair (MMR) in sporadic endometrial cancers with microsatellite instability (MSI), a thorough mutation analysis was performed on the human mismatch repair gene MSH3. Methods: Twenty-eight MSI-positive endometrial cancers were investigated for m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Society for Gynecologic Investigation 1998-07, Vol.5 (4), p.210-216
Hauptverfasser: Swisher, Elizabeth M., Mutch, David G., Herzog, Thomas J., Rader, Janet S., Kowalski, Lynn D., Elbendary, Alla, Goodfellow, Paul J.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To clarify the origin of defective mismatch repair (MMR) in sporadic endometrial cancers with microsatellite instability (MSI), a thorough mutation analysis was performed on the human mismatch repair gene MSH3. Methods: Twenty-eight MSI-positive endometrial cancers were investigated for mutations in the human mismatch repair gene MSH-3 using single-strand conformation variant (SSCV) analysis of all 24 exons. All variants were sequenced. Loss of heterozygosity was investigated at all MSH3 polymorphisms discovered. A subset of tumors were investigated for methylation of the 5′ promoter region of MSH3 using Southern blot hybridization. Results: An identical single-base deletion (ΔA) predicted to result in a truncated protein was discovered in six tumors (21.4%). This deletion occurs in a string of eight consecutive adenosine residues (A8). Because simple repeat sequences are unstable in cells with defective MMR, the observed mutation may be an effect, rather than a cause, of MSI. Evidence of inactivation of the second MSH3 allele in tumors with the ΔA mutation would strongly support a causal role for these MSH3 mutations. However, there was no evidence of a second mutation, loss of sequences, or methylation of the promoter region in any of the tumors with the ΔA mutation. Conclusion: Although the ΔA mutation is a frequent event in sporadic MSI-positive endometrial cancers, it may not be causally associated with defective DNA MMR.
ISSN:1071-5576
1556-7117
DOI:10.1177/107155769800500409